Multicenter examination showed biomarkers in cerebrospinal fluid consistently distinguished MS from other ...

Detailed price information for Denali Therapeutics Inc (DNLI-Q) from The Globe and Mail including charting and trades.

JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced the presentation of four ...

A new study reveals how Epstein-Barr virus may provoke immune cells to attack the brain, offering fresh hope for treating ...

Yawning has long been dismissed as a sign of boredom or fatigue, a social cue we mostly try to suppress in meetings and on ...

Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology -HYOGO, Japan--(BUSINESS WIRE)--JCR Pharmaceuticals ...

High blood pressure, heart disease, and hyperlipidemia are some of the top modifiable factors linked to dementia risk, mounting evidence suggests.

Current approved drug therapies for Alzheimer’s, while effective for some patients, can carry risks such as brain swelling and are also costly.

Shareholder/Analyst Call February 5, 2026 3:30 PM ESTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...

By Dr. Liji Thomas, MD By seamlessly tracking brain growth from the womb into early life, researchers uncover when key brain regions surge and how subtle sex differences emerge before birth. Study: ...

BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...

Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of investigational therapies and diagnostic assays for patients with Alzheimer's disease (AD) and other ...